Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada by LaurenEBS | Oct 13, 2021
The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database by LaurenEBS | Jun 13, 2021
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003 single arm phase II trial by LaurenEBS | May 13, 2021
A descriptive cost-analysis of MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma by LaurenEBS | May 13, 2021
Lenalidomide Maintenance After Autologous Stem Cell Transplant: The Utility of Real-World Data and Future Areas of Study by LaurenEBS | Mar 13, 2021
